Research Article

FAS and FASL Gene Polymorphisms Are Not Associated with Hepatitis B Virus Infection Based on a Case-Control Study in a Brazilian Population

Table 1

Comparison of genotype frequencies of the FAS and FASL polymorphisms among the HBV patients and healthy controls.

Genotype profileHBV patients ( ) n (%)Healthy controls ( ) n (%)Adjusted OR*95% CIP value

FAS-670 A>G
 AA25 (21.55)51 (21.70)
 AG55 (47.41)116 (49.36)
 GG36 (31.04)68 (28.94)
 AG + GG91 (78.45)184 (78.30)1.04270.60–1.810.9154
FAS-1377 G>A
 GG94 (81.04)185 (78.73)
 GA20 (17.24)44 (18.72)
 AA02 (01.72)06 (02.55)
 GA + AA22 (18.96)50 (21.27)0.86230.49–1.530.8283
Ivs2ntFASLG-124 A>G
 AA100 (86.21)198 (84.26)
 AG15 (12.93)35 (14.89)
 GG01 (00.86)02 (00.85)
 AG + GG16 (13.79)37 (15.74)0.87240.45–1.680.8936
Ivs3ntFASLG-169 T>ΔT
 TT87 (75.00)177 (75.32)
 T/ΔT25 (21.55)56 (23.83)
 ΔT/ΔT04 (03.45)02 (00.85)
 T/ΔT + ΔT/ΔT29 (25.00)58 (24.68)0.99870.59–1.690.2403
FASLG-844 C>T
 CC51 (43.96)99 (42.13)
 CT47 (40.52)112 (47.66)
 TT18 (15.52)24 (10.21)
 CT + TT65 (56.04)136 (57.87)0.95270.60–1.520.2513

Multiple logistic regression; Chi-squared test; G test.